Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Go back to Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Forte Biosciences (FBRX) Reports Q2 Loss of $0.42/sh

August 14, 2023 4:21 PM EDT

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.42), versus ($0.21) reported last year.

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

... More